The entire customer centric movement along with the advent of chemical, biological, gene and cell-based therapies will have a significant impact on the supply chain of the future.
Reaching clients directly for further study and research available at the point of need—would create a strong competitive advantage. Biologics (gene- and cell-based therapies) require a unique supply chain to support each and every patient. The number of potential shipment lanes becomes endless and the temperature-controlled requirements will also evolve to support both raw material as well as finished goods transport. All the Shipping operations are organized by outsourcing.
Fedex is the major outsourcing partner in the shipping line. The shipping system can be traced in real time.